Financial Performance - The company's revenue for Q1 2022 was ¥88,988,254.41, representing a 13.90% increase compared to ¥78,131,506.74 in the same period last year[3] - Net profit attributable to shareholders was ¥15,947,281.75, up 26.42% from ¥12,614,085.10 year-on-year[3] - Net profit for the current period was ¥15,947,281.75, representing a 26.5% increase from ¥12,614,085.10 in the previous period[21] - Operating profit increased to ¥18,091,337.01, a rise of 21.5% compared to ¥14,870,341.28 in the last period[21] - The company reported a total comprehensive income of ¥15,947,281.75, an increase from ¥12,614,085.10 in the last period[22] Cash Flow - The net cash flow from operating activities increased significantly by 183.19%, reaching ¥28,896,632.28 compared to ¥10,203,914.19 in the previous year[3] - Cash flow from operating activities generated a net amount of ¥28,896,632.28, significantly higher than ¥10,203,914.19 in the prior period[25] - The cash flow from investment activities showed a remarkable increase of 1675.51%, amounting to ¥119,613,408.21, primarily due to bank wealth management redemptions[7] - Cash flow from investment activities yielded a net inflow of ¥119,613,408.21, compared to a net outflow of ¥7,592,060.74 in the previous period[26] Assets and Liabilities - The company's total assets at the end of the reporting period were ¥888,108,199.30, a 2.46% increase from ¥866,743,912.77 at the end of the previous year[3] - The total current liabilities rose to RMB 84,170,030.09, up from RMB 78,436,253.75, indicating an increase of approximately 7.0%[18] - The company's total equity attributable to shareholders reached RMB 793,674,145.93, compared to RMB 777,731,498.34 at the beginning of the year, marking an increase of about 2.0%[18] - The total liabilities of the company were RMB 94,434,053.37, an increase from RMB 89,012,414.43, representing a growth of about 6.0%[18] Shareholder Information - The company reported a total of 12,956 common shareholders at the end of the reporting period[8] - The company has a total of 60,000,000 restricted shares, which will remain restricted until November 22, 2024[12] Research and Development - Research and development expenses rose by 47.52% to ¥3,859,664.19, reflecting the company's commitment to enhancing product competitiveness[6] - Research and development expenses rose to ¥3,859,664.19, up 47.3% from ¥2,616,376.19 in the previous period[21] Earnings Per Share - The company's basic earnings per share decreased by 4.76% to ¥0.20 from ¥0.21 in the same period last year[3] - The basic and diluted earnings per share were both ¥0.20, slightly down from ¥0.21 in the previous period[22] Future Plans - The company has announced plans for future expansion and investment in new technologies, although specific financial figures were not disclosed in the report[13]
正强股份(301119) - 2022 Q1 - 季度财报